Table 1. Characteristics and Prevalent Symptoms of 202 Patients Positive for SARS-CoV-2.
Characteristics | No. of patients | Prevalence, % (95% CI)a |
---|---|---|
Age, median (IQR), y | 56 (45-67) | |
Sex | ||
Men | 97 | 48.0 (41.0-55.1) |
Women | 105 | 52.0 (44.9-59.0) |
Smoking status | ||
Never | 139 | 68.8 (61.9-75.1) |
Ever | 63 | 31.2 (24.9-38.0) |
Current alcohol drinking | ||
No | 80 | 39.6 (32.8-46.7) |
Yes | 122 | 60.4 (53.3-67.2) |
Comorbidity | ||
None | 89 | 44.1 (37.1-51.2) |
Any | 113 | 55.9 (48.8-62.9) |
Indication for testing | ||
Exposure to confirmed SARS-CoV-2 contact | 70 | 34.7 (28.1-41.7) |
Symptomatic presentation | 132 | 65.4 (58.3-71.9) |
Symptoms based on the ARTIQb | ||
Fever | 113 | 55.9 (48.8-62.9) |
Dry cough or coughing up mucus | 122 | 60.4 (53.3-67.2) |
Blocked nose | 73 | 36.1 (29.5-43.1) |
Problems breathing | 83 | 41.1 (34.2-48.2) |
Headache | 86 | 42.6 (35.7-49.7) |
Sore throat | 63 | 31.2 (24.9-38.1) |
Muscle or joint pains | 90 | 44.6 (37.6-51.7) |
Chest pain | 33 | 16.3 (11.5-22.2) |
Sinonasal pain | 35 | 17.3 (12.4-23.3) |
Loss of appetite | 110 | 54.5 ( 47.3-61.5) |
Tiredness | 138 | 68.3 (61.4-74.7) |
Diarrhea | 88 | 43.6 (36.6-50.7) |
Nausea | 40 | 19.8 (14.5-26.0) |
Vomiting | 13 | 6.4 (3.5-10.8) |
Abdominal pain | 25 | 12.4 (8.2-17.7) |
Dizziness | 28 | 13.9 (9.4-19.4) |
Abbreviations: ARTIQ, Acute Respiratory Tract Infection Questionnaire; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
95% CIs were calculated using Clopper-Pearson method.
Patients were asked, “During the 2 weeks preceding the swab administration of the questionnaire, did you experience any of the following symptoms?” (Prevalence is combined responses of “a little” or “a lot.”)